Silent myocardial ischemia in type 2 diabetic patients :: benefits of intensive treatment of cardiovascular risk factors and optimal glycemic equilibrium

被引：0
|
作者：
Jacqueminet, S. [1 ]
Barthelemy, O. [2 ]
Rouzet, F. [3 ]
Isnard, R. [2 ]
Halbron, M. [1 ]
Bouzamondo, A. [4 ]
Le Guludec, D. [3 ]
Grimaldi, A. [1 ]
Metzger, J. P. [2 ]
Le Feuvre, C. [2 ]
机构：
[1] Grp Hosp Pitie Salpetriere, Serv Diabetol Nutr & Malad Metab, F-75634 Paris, France
[2] Grp Hosp Pitie Salpetriere, Inst Cardiol, F-75634 Paris, France
[3] Hop Bichat Claude Bernard, Nucl Med Serv, F-75877 Paris, France
[4] Grp Hosp Pitie Salpetriere, Serv Pharmacol, F-75634 Paris, France
来源：
DIABETES & METABOLISM | 2008年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4
引用
收藏
页码：A40 / A41
页数：2
相关论文
共 50 条
  • [1] Prevalence of silent myocardial ischemia and coronaropathy in type 2 diabetic patients since taking optimal charge of cardiovascular risk factors
    Jacqueminet, S.
    Bartelemy, O.
    Rouzet, F.
    Isnard, R.
    Halbron, M.
    Bouzamondo, A.
    Le Guludec, D.
    Grimaldi, A.
    Metzger, J. P.
    Le Feuvre, C.
    DIABETES & METABOLISM, 2008, 34 : A70 - A70
  • [2] Inflammatory cardiovascular risk markers and silent myocardial ischemia in type 2 diabetic patients
    Malesevic, Gabrijela
    Popovic-Pejicic, Snjezana
    Markovic, Aleksandra
    Soldat-Stankovic, Valentina
    VOJNOSANITETSKI PREGLED, 2022, 79 (06) : 584 - 590
  • [3] Risk Factors for Silent Myocardial Ischemia in Type II Diabetic Patients
    Forood, Afsaneh
    Masomi, Mohammad
    IRANIAN HEART JOURNAL, 2008, 9 (02): : 37 - 42
  • [4] Control of Cardiovascular Risk Factors in Asymptomatic Type 2 Diabetic Patients: Consequences on Myocardial Ischemia and Silent Coronary Stenoses
    Cosson, Emmanuel
    Avignon, Antoine
    Sultan, Ariane
    Minh Tuan Nguyen
    Valensi, Paul
    DIABETES, 2013, 62 : A113 - A113
  • [5] Frequency of silent myocardial ischemia in type 2 diabetic patients and the relation with poor glycemic control
    M. Araz
    Z. Celen
    I. Akdemir
    V. Okan
    Acta Diabetologica, 2004, 41 : 38 - 43
  • [6] Risk factors for silent myocardial ischemia in high-risk type 1 diabetic patients
    Sultan, A
    Piot, C
    Mariano-Goulart, D
    Rasamisoa, M
    Renard, E
    Avignon, A
    DIABETES CARE, 2004, 27 (07) : 1745 - 1747
  • [7] Frequency of silent myocardial ischemia in type 2 diabetic patients and the relation with poor glycemic control
    Araz, M
    Celen, Z
    Akdemir, I
    Okan, V
    ACTA DIABETOLOGICA, 2004, 41 (02) : 38 - 43
  • [8] Intensive cardiovascular risk factors therapy and prevalence of silent myocardial ischaemia in patients with type 2 diabetes
    Barthelemy, Olivier
    Jacqueminet, Sophie
    Rouzet, Francois
    Isnard, Richard
    Bouzamondo, Anissa
    Le Guludec, Dominique
    Grimaldi, Andre
    Metzger, Jean-Philippe
    Le Feuvre, Claude
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2008, 101 (09) : 539 - 546
  • [9] Osteoprotegerin, thiazolidinediones treatment, and silent myocardial ischemia in type 2 diabetic patients
    Sultan, Ariane
    Avignon, Antoine
    Galtier, Florence
    Piot, Christophe
    Mariano-Goulart, Denis
    Dupuy, Anne Marie
    Cristol, Jean Paul
    DIABETES CARE, 2008, 31 (03) : 593 - 595
  • [10] Screening for silent myocardial ischemia in type 2 diabetic patients?
    Dvorscak, D.
    Trsinski, D.
    Koscak, K.
    Slunjski, D.
    Kukolja, K.
    Dumicic, J.
    Jeric, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 357 - 357
12345